Search

Showing total 6 results
Start Over Search Limiters Available in Library Collection Topic antimicrobial resistance Publication Type eBooks
6 results

1. Feature Paper in Antibiotics for 2019.

Author

Lipman, Jeffrey and Lipman, Jeffrey

Subjects
Medicine, Acinetobacter baumannii, Antibiotics, Antimicrobial resistance, CRE, Enterobacteriaceae, HPLC-MS/MS, One Health, Pseudomonas aeruginosa, Singapore, Start Smart then Focus, actinomycetes, anti-Candida activity, antibacterial, antibacterials, antibiotic prescribing, antibiotic resistance, antibiotic stewardship, antibiotic utilization, antibiotics, antifungal, antifungals, antimicrobial resistance, antimicrobial stewardship, antimicrobials, bacteriophages, behavior change, bioactivity, biofilms, biosynthesis, broad-spectrum agents, camphorimine, carbapenem-resistant, carbapenem-resistant Enterobacteriaceae, chloramfenicol, clinical trials, cost-effectiveness analysis, cost-utility analysis, days of therapy, economic evaluation, efflux inhibitors, efflux pumps, erm(41), extended-spectrum beta-lactamases, florfenicol, fluoroquinolones, general practitioners, guideline, guidelines, health equity assessment tool, health inequalities, hospital epidemiology, implementation, inappropriate prescribing, infection control, infection prevention, infectious disease, methicillin-resistant Staphylococcus aureus, mutations, mycobacteria, n/a, non-target feed, novel antimicrobials, out-of-hours care, phage therapy, piperine, piperlongumine, policy analysis, polyketide synthases, polyketides, practitioners cooperative, primary care, public health, quality improvement, quality indicators, quality of care, resistance, silver complexes, stakeholder consultation, swine, synergy, thiamfenicol, urinary tract infections, validation, verapamil
Abstract

Summary: There has been much speculation about a possible antibiotic Armageddon; this would be the result of having untreatable post-operative infections, and similarly untreatable complications after chemotherapy. The now famous "O'Neill Report" (https://amr-review.org/) suggests that more people could die from resistant bacterial infections by 2050 than from cancer. We are still learning about all the subtle drivers of antibiotic resistance, and realizing that we need a single "whole of health" co-ordinated policy. We ingest what we sometimes feed to animals. There do not seem to be any new classes of antibiotics on our horizon. Perhaps something that has been around "forever" will come to our rescue-bacteriophages! Nevertheless, we have to do things differently, use antibiotics appropriately, for the correct indication, for the correct duration and with the correct dose, and with that, practice good antibiotic stewardship. Whilst by no means comprehensive, this book does cover some of the many topics of antibiotic stewardship. It also addresses some of the older antibiotics, some new combinations, and even some new agents. Last, and by no means least, there are two excellent articles on bacteriophages.

2. Study of Microbiological Safety in the Food Chain.

Author

Zdolec, Nevijo and Zdolec, Nevijo

Subjects
Humanities, Social interaction, Aspergillus, Bacillus, Cladosporium, Croatian regions, Ehrlich reaction, Fusarium, Lactobacillus johnsonii, Lactobacillus zeae, MALDI-TOF-MS, PCR, PCR-ITS-RFLP, Penicillium, Toxoplasma gondii, Yersinia enterocolitica, antimicrobial resistance, bacteriocins, biogenic amines, biological hazards, colony morphology, creatine, dry aged beef, dry-cured hams, egg, egg quality, emerging foodborne pathogens, enterococcal species, enterococci, ewe, food chain information, index, lactobacilli, lactococci, meat products, meat safety, microbial flora, microbiome, milk, milk lump cheese, mold, n/a, probiotics, rancidity, raw goat milk, restriction enzyme, ripened cheese, safety, sensory evaluation, surface moulds, virulence factor
Abstract

Summary: Ensuring microbiological safety in the food (of animal origin) chain is a challenging task due to the complex interactions among animals, humans and the environment. However, technological and analytical advances in recent years have provided a broader insight into microbiological hazards in the food chain and risk assessment. The objective of the proposed Special Issue "Study of Microbiological Safety in the Food Chain" was therefore to obtain scientific papers addressing microbiological hazards in the food chain, such as bacterial antimicrobial resistance, bacterial or fungal spoilage of foods, the antimicrobial potential of the indigenous microbiota, the aminogenic or amine-reducing capacity of the microbiota, and papers that apply novel methods to study the food microbiome to discover potential, previously unknown microbial hazards. This Special Issue of the journal Processes entitled "Study of Microbiological Safety in the Food Chain" consists of nine research papers and one review paper. Four papers focus on the microbiological aspects of milk and dairy products, three on meat and meat products, two on eggs, and one on various market foods. The microorganisms of interest were species of lactobacilli, enterococci and molds, Yersinia enterocolitica, Bacillus cereus and the general microbiota in certain foods.

3. Nanomaterials for Biomedical and Biotechnological Applications.

Author

Ferraro, Angelo and Ferraro, Angelo

Subjects
Biotechnology, Technology: general issues, COVID-19, Chlorella vulgaris, Enterococcus faecalis, MTT assay, Parkinson's disease, actuation system, animal model, anti-arthritic activity, antibiotics, antimicrobial resistance, biological samples, biomarkers, biosensors, blood-brain barrier, boron nitride, cerium oxide nanoparticles, chitosan, ciprofloxacin, clay, clinical trials, colorectal cancer, column-switching chromatography, covalent immobilization, cubic particles, cytotoxic medication, drug delivery, drug release, drug targeting, economic analysis, epigenetic changes, genetic pathways, gold nanoparticles, harvesting process optimization, hemocompatibility, immune response, liver and kidney infections, magnetic driving, magnetic gels, magnetic hyperthermia, magnetic lipogels, magnetic nanoparticles, methotrexate, microfibers, microwave-synthesized magnetite particles, n/a, nanocomposite films, nanoemulsion, nanofibers, nanomedicine, nanomodified surfaces, nanoparticle functionalization, nanotechnology, neurodegenerative disease, neutron capture reaction, nuclear medicine, on-line extraction, ophthalmic applications, optimization, organic and inorganic nanoparticles, orthopedic, oxidative stress, papain, physicochemical properties, phytomedicine, plant design and process engineering, prognostic, response surface methodology, restricted access media, rheumatoid arthritis, sanitizers, self-assembly, stability studies, supramolecular hydrogels, synthesis methods, theranostic nanomaterials, vaccines, wine
Abstract

Summary: The need for constant improvement to reach a high standard of safety and to make nanomaterials accessible for marketing has generated a considerable number of scientific papers that highlight new important aspects to be considered, such as synthesis, stability, biocompatibility, and easy manipulation. In order to provide a comprehensive update on the latest discoveries concerning nanomaterials, this reprint presents 14 scientific papers, 10 research articles and 4 reviews, that deal with biomedical and biotechnological applications of nanomaterials.

5. Antimicrobial Prescribing and Stewardship, 1st Volume.

Author

Ashiru-Oredope, Diane and Ashiru-Oredope, Diane

Subjects
Medicine, AMS, Africa, COVID-19, CwPAMS App, FilmArray, Ghana, Gram negative bacteremia, Helicobacter pylori, LMICs, Nepal, PDSA cycle, SARS-CoV-2, Theoretical Domains Framework, UK, Uganda, acute otitis media, adolescents, amoxicillin, animal health, anti-infective agents, antibiotic, antibiotic resistance, antibiotic stewardship, antibiotic stewardship program, antibiotic therapy, antibiotic use, antibiotics, antibiotics use, antimicrobial, antimicrobial prescribing, antimicrobial resistance, antimicrobial resistance (AMR), antimicrobial stewardship, antimicrobial stewardship (AMS), antimicrobial stewardship intervention, antimicrobials, attitudes, bacteremia, barriers and enablers, behavior change, bloodstream infection, bone infection, burn care, candidemia, children, clarithromycin, clinical pathways, community health workers, complementarity, complex intervention, coronavirus, critically ill patients, culture and sensitivity testing, delayed/back-up prescribing, developing countries, emergency departments, encephalitis, enterococcal, epidemiology, ethical trials, family practice, fluoroquinolones, follow-up blood cultures, fosfomycin, general practice, health policy, health practitioners, hematologic diseases, infection prevention and control, joint infection, knowledge, leaflet, low- and middle-income countries, low-and middle-income countries, medical students, meningitis, metronidazole, microbial resistance, mortality, multidisciplinary, multiplex PCR, nurse, obesity, older adults, one health, osteomyelitis, outcomes, pediatric infectious disease, pharmacist, pharmacy, pharyngitis, prescribing, prescribing appropriateness, prescription, prospective audit and feedback, proton pump inhibitors, public health, qualitative, quality of health care, rapid diagnostic technology, resistance, resistance patterns, risk factors, sepsis, septic arthritis, smartphone apps, stewardship, therapy, training, upper respiratory tract infections, urinary infection, urinary tract infections (UTI), veterinary, wound care, wound management
Abstract

Summary: This Antimicrobial Prescribing and Stewardship Issue (volume 1) consist of manuscripts, including original research, review articles, case series, and opinion papers for topics related to antimicrobial (antibiotic, antifungal) stewardship, including: Disease-based/organism-based antimicrobial stewardship;Diagnostic stewardship;Influence of antimicrobial utilisation changes in antimicrobial resistance;Impact of antimicrobial stewardship on quality performance measures and patient outcomes;Novel antimicrobial stewardship education and training approaches or interventions aimed at the public and/or healthcare workers;Behavioural change approaches to antimicrobial stewardship;Collaborative practice agreements in antimicrobial stewardship;Antimicrobial stewardship in special populations (e.g., paediatrics, geriatrics, emergency medicine, hematology/oncology);Tackling AMR through antimicrobial stewardship in low- and middle-income countries;Antimicrobial stewardship for animal health;Antimicrobial stewardship in alternative settings (e.g., community practice, long-term care, and resource-limited small and rural hospitals);Antimicrobial use and stewardship in the context of the COVID-19 pandemic;Global collaborations to tackle AMR through antimicrobial stewardship.